Skip to content

AstraZeneca is pleased to announce that IMFINZI® (Durvalumab) injection has been assigned a unique HCPCS code by the Centers for Medicare & Medicaid S

AstraZeneca is pleased to announce that IMFINZI® (Durvalumab) injection has been assigned a unique HCPCS code by the Centers for Medicare & Medicaid Services (CMS).

1/20/2019

AstraZeneca is pleased to announce that IMFINZI® (Durvalumab) injection has been assigned a unique HCPCS code by the Centers for Medicare & Medicaid Services (CMS).


Effective for dates of services on or after January 1, 2019, the following code can be used to identify IMFINZI® (Durvalumab) when billing across settings of care as noted in the Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs available at:


https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-24243.pdf


Code

Description

Vial Size

Billing Units

NDC

J9173

Injection, Durvalumab, 10 mg1

500 mg/10 mL

50 units

0310-4611-50

120 mg/2.4 mL

12 units

0310-4500-12


Each provider is responsible for ensuring all coding is accurate and documented in the medical record based on the condition of the patient. The use of this information does not guarantee reimbursement. Healthcare providers are encouraged to contact payers to confirm code adoption and approved usage prior to submitting claims.


AstraZeneca Access 360™ can help with questions you may have about coding and reimbursement. For additional assistance, please contact your Reimbursement Counselor at 1-833-360-4357, Monday through Friday from 8 AM to 8 PM Eastern Time, or visit www.MyAccess360.com.


Thank you,


 

References: 1. Centers for Medicare & Medicaid Services. Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. November 2, 2018.


If in the future, you no longer want to receive e-mails about IMFINZI, call the AstraZeneca Information

Center at 1$B!>(J800$B!>(J236$B!>(J9933.


IMFINZI is a registered trademark of the AstraZeneca group of companies.

 

The Information Center at AstraZeneca

1800 Concord Pike, PO Box 15437, Wilmington, DE 19850$B!>(J5437


©2018 AstraZeneca. All rights reserved. US-23378 Last Updated 10/18



Powered By GrowthZone